Six senators are railing on Sanofi for its role in a Zika pricing dustup that’s gained considerable attention since last year.

The EU's highest court ruled that EU national courts don't need scientific proof to consider a vaccine as defect.

Bexsero has been helping drive revenue growth for GSK, but now, with an EU approval, Pfizer’s Trumenba is set to challenge it in that lucrative market.

A Sanofi executive has explained the rationale behind the company’s Zika vaccine development plan and is issuing a defense against claims his company is out to…

Serum Institute of India CEO Adar Poonawalla struck a deal on Tuesday to pick up a defunct Czech outfit for €72 million.

WHO plans real-world pilot studies of GlaxoSmithKline’s malaria jab Mosquirix in three African countries.

Vaccination rates among kindergarteners reached a record high in California after a tougher vaccine law went into effect.

Sanofi Pasteur's dengue vaccine Dengvaxia will have to undergo phase 4 testing in Malaysia.